Works matching DE "EPIDERMAL growth factor receptors"

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Potassium Iodide Induces Apoptosis in Salivary Gland Cancer Cells.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 11, p. 5199, doi. 10.3390/ijms26115199
    By:
    • Skrypnyk, Maksym;
    • Yatsenko, Tetiana;
    • Riabets, Oleksandra;
    • Zuieva, Olga;
    • Rodionova, Iryna;
    • Skikevych, Margarita;
    • Salama, Yousef;
    • Osada, Taro;
    • Tobita, Morikuni;
    • Takahashi, Satoshi;
    • Hattori, Nobutaka;
    • Takahashi, Kazuhisa;
    • Hattori, Koichi;
    • Heissig, Beate
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Lung cancer news.

    Published in:
    Oncolog-Hematolog, 2025, n. 71, p. 3
    By:
    • Grigorescu, Alexandru C.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2025, v. 149, n. 6, p. 542, doi. 10.5858/arpa.2024-0014-OA
    By:
    • Zhenhao Qi;
    • Ha, Thomas;
    • Wenqin Feng;
    • Karnoub, Maha;
    • Pereira, Kaline;
    • Ryota Shiga;
    • Smit, Egbert F.;
    • Yasushi Goto;
    • De Langen, Adrianus Johannes;
    • Koichi Goto;
    • Velasco Roth, Anne Marie;
    • Khambata-Ford, Shirin
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf048
    By:
    • Ueno, Naoto T;
    • Cottone, Francesco;
    • Dunton, Kyle;
    • Jacot, William;
    • Yamashita, Toshinari;
    • Sohn, Joohyuk;
    • Tokunaga, Eriko;
    • Prat, Aleix;
    • Tsurutani, Junji;
    • Park, Yeon Hee;
    • Rugo, Hope S;
    • Xu, Binghe;
    • Cardoso, Fatima;
    • Mitri, Zahi;
    • Mahtani, Reshma;
    • Aguilar, Cecilia Orbegoso;
    • Xiao, Feng;
    • Harbeck, Nadia;
    • Cameron, David A;
    • Modi, Shanu
    Publication type:
    Article
    42
    43
    44

    Exploring the anticancer potential of Jerantinine A from Tabernaemontana coronaria against prostate, breast, and ovarian cancers: a computational approach.

    Published in:
    Journal of Complementary & Integrative Medicine, 2025, v. 22, n. 2, p. 363, doi. 10.1515/jcim-2024-0443
    By:
    • Kannappan, Poornima;
    • Kaniyur Chandrasekaran, Meenakshi;
    • Vani Raju, Manikandan;
    • Gopalakrishnan, Shankari;
    • Dhamodharan, Prabhu;
    • Muthaiyan Ahalliya, Rathi;
    • Palanisamy, Chella Perumal;
    • Raju, Balaji;
    • Velliyur Kanniappan, Gopalakrishnan
    Publication type:
    Article
    45
    46
    47
    48
    49

    Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity.

    Published in:
    Antioxidants, 2025, v. 14, n. 5, p. 612, doi. 10.3390/antiox14050612
    By:
    • Quagliariello, Vincenzo;
    • Di Mauro, Annabella;
    • Ferrara, Gerardo;
    • Bruzzese, Francesca;
    • Palma, Giuseppe;
    • Luciano, Antonio;
    • Canale, Maria Laura;
    • Bisceglia, Irma;
    • Iovine, Martina;
    • Cadeddu Dessalvi, Christian;
    • Maurea, Carlo;
    • Barbato, Matteo;
    • Inno, Alessandro;
    • Berretta, Massimiliano;
    • Paccone, Andrea;
    • Mauriello, Alfredo;
    • Fonderico, Celeste;
    • Maratea, Anna Chiara;
    • Maurea, Nicola
    Publication type:
    Article
    50